Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A colon tumor model for anticancer agent evaluation.

D P Griswold, T H Corbett

    Cancer
    |December 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Minors' rights to refuse medical treatment requested by their parents: remaining issues.

    Journal of the American Academy of Nurse Practitioners·2002
    Same author

    Methylene-gem-difluorocyclopropane analogues of nucleosides: synthesis, cyclopropene-methylenecyclopropane rearrangement, and biological activity.

    Journal of medicinal chemistry·2001
    Same author

    High-performance liquid chromatographic method for the estimation of the novel investigational anti-cancer agent SR271425 and its metabolites in mouse plasma.

    Journal of chromatography. B, Biomedical sciences and applications·2001
    Same author

    Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.

    Journal of natural products·2001
    Same author

    Total structure determination of apratoxin A, a potent novel cytotoxin from the marine cyanobacterium Lyngbya majuscula.

    Journal of the American Chemical Society·2001
    Same author

    Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

    Journal of medicinal chemistry·2001
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    New mouse colon tumor models were developed using chemical carcinogens. These models showed varied tumor grades and metastatic potential, responding to chemotherapy agents like cyclophosphamide, offering promise for cancer research.

    Area of Science:

    • Oncology
    • Carcinogenesis
    • Experimental Medicine

    Background:

    • Developing reliable animal models is crucial for understanding colon cancer progression.
    • Chemical induction provides a method for generating diverse tumor characteristics.

    Purpose of the Study:

    • To establish and characterize new transplantable mouse colon tumor lines.
    • To evaluate the utility of these models in preclinical cancer research.

    Main Methods:

    • Colon tumors were induced in mice using four different chemical carcinogens.
    • Successful tumor lines were maintained via subcutaneous transplantation.
    • Tumor characteristics including grade, doubling time, and metastatic potential were assessed.

    Main Results:

    Related Experiment Videos

    • Four distinct transplantable colon tumor lines were successfully established from 82 attempts.
    • Tumor grades ranged from adenocarcinoma (II) to undifferentiated carcinoma (IV).
    • Significant variation in volume-doubling times and metastatic potential (5-100%) was observed.
    • Tumor lines demonstrated sensitivity to cyclophosphamide, 5-fluorouracil, and nitrosoureas, mirroring human responses.

    Conclusions:

    • The established mouse colon tumor lines represent valuable preclinical models.
    • These models exhibit diverse biological behaviors and drug sensitivities, relevant to human colon cancer.
    • Further research utilizing these models is warranted to explore novel therapeutic strategies.